StockData
Aprea Therapeutics, Inc. logo

Aprea Therapeutics, Inc. (APRE) stock

APRENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$0.46+0.01 (+2.60%)

Close on Nov 18, 2026Market cap $5.85MP/E –Yield –

Earnings

Aprea Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 15, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.09
Latest guidance
Issued
Mar 15, 2022 · 1 item

Quarterly results

Revenue and earnings per share from each of Aprea Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 15, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026before the open––-$0.09Release
Q2 FY2026ended Jun 30, 2026Aug 12, 2026before the open–––Release
Q1 FY2026ended Mar 31, 2026May 13, 2026before the open–––Release
Q4 FY2025ended Dec 31, 2025Mar 16, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025before the open–––Release
Q2 FY2025ended Jun 30, 2025Aug 12, 2025before the open–––Release
Q1 FY2025ended Mar 31, 2025May 14, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Mar 25, 2025before the open$205.82K+1362.3%-$0.49Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024before the open$400.00K–-$0.64Release
Q2 FY2024ended Jun 30, 2024Aug 12, 2024before the open$600.00K–-$0.58Release
Q1 FY2024ended Mar 31, 2024May 14, 2024before the open$380.57K–-$0.67Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Aprea Therapeutics guided for has been reported

Guidance history

Every forecast Aprea Therapeutics put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Mar 15, 2022cash burnFY2022$25.00M – $30.00MNew
Nov 8, 2021cash burnFY2021$30.00M – $35.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Aprea Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. News
  4. Results
  5. Results
  6. Results
  7. Results
  8. Update
  9. Update
  10. Update
  11. Update
  12. Results
  13. Results
  14. News
  15. Update

See a number that looks wrong?